S M Fish1, R Proujansky, W W Reenstra. 1. Nemours Research Programmes of the Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA.
Abstract
BACKGROUND: Inflammatory bowel disease (IBD) is characterised by chronic intestinal inflammation and increased epithelial permeability. Both tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) have been implicated in IBD. AIMS: To understand better the effects of these cytokines on epithelial cell function. METHODS: T84 cells were cultured with IFN-gamma and TNF-alpha and changes in transepithelial resistance (TER), fluorescein isothiocyanate (FITC) dextran flux, short circuit current (I(sc)), cystic fibrosis transmembrane conductance regulator (CFTR) protein levels, cell morphology, TNF receptor gene expression, and apoptosis were assayed. RESULTS: Relative to controls, significant changes (p<0.05) occurred in cells incubated with IFN-gamma for two days: TER was decreased to 20 (6.2)%, FITC-dextran flux was increased by 109 (19)-fold, cAMP and Ca dependent I(sc) were decreased to 51 (6.4)% and 24 (2.2)%, respectively, and CFTR levels were decreased to 47 (11)%. Cell morphology was altered but cell death was not induced. TNF receptor mRNA levels were increased. When added with IFN-gamma, TNF-alpha accelerated IFN-gamma dependent changes. Relative to controls, significant changes occurred after one day of culture with IFN-gamma plus TNF-alpha: TER was decreased to 27 (3.5)%, FITC-dextran flux was increased by 185 (45)-fold, and cAMP and Ca dependent I(sc) were decreased to 66 (12)% and 35 (6.8)%, respectively. TNF-alpha also enhanced IFN-gamma dependent changes in cell morphology but did not induce cell death. CONCLUSION: IFN-gamma alters T84 cell epithelial properties and TNF-alpha can enhance these effects, perhaps due to IFN-gamma dependent increases in TNF receptor gene expression. Overall, these studies suggest that in IBD, TNF-alpha may have synergistic effects on IFN-gamma mediated alterations of epithelial cell function.
BACKGROUND:Inflammatory bowel disease (IBD) is characterised by chronic intestinal inflammation and increased epithelial permeability. Both tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) have been implicated in IBD. AIMS: To understand better the effects of these cytokines on epithelial cell function. METHODS: T84 cells were cultured with IFN-gamma and TNF-alpha and changes in transepithelial resistance (TER), fluorescein isothiocyanate (FITC) dextran flux, short circuit current (I(sc)), cystic fibrosis transmembrane conductance regulator (CFTR) protein levels, cell morphology, TNF receptor gene expression, and apoptosis were assayed. RESULTS: Relative to controls, significant changes (p<0.05) occurred in cells incubated with IFN-gamma for two days: TER was decreased to 20 (6.2)%, FITC-dextran flux was increased by 109 (19)-fold, cAMP and Ca dependent I(sc) were decreased to 51 (6.4)% and 24 (2.2)%, respectively, and CFTR levels were decreased to 47 (11)%. Cell morphology was altered but cell death was not induced. TNF receptor mRNA levels were increased. When added with IFN-gamma, TNF-alpha accelerated IFN-gamma dependent changes. Relative to controls, significant changes occurred after one day of culture with IFN-gamma plus TNF-alpha: TER was decreased to 27 (3.5)%, FITC-dextran flux was increased by 185 (45)-fold, and cAMP and Ca dependent I(sc) were decreased to 66 (12)% and 35 (6.8)%, respectively. TNF-alpha also enhanced IFN-gamma dependent changes in cell morphology but did not induce cell death. CONCLUSION:IFN-gamma alters T84 cell epithelial properties and TNF-alpha can enhance these effects, perhaps due to IFN-gamma dependent increases in TNF receptor gene expression. Overall, these studies suggest that in IBD, TNF-alpha may have synergistic effects on IFN-gamma mediated alterations of epithelial cell function.
Authors: W A Stack; S D Mann; A J Roy; P Heath; M Sopwith; J Freeman; G Holmes; R Long; A Forbes; M A Kamm Journal: Lancet Date: 1997-02-22 Impact factor: 79.321
Authors: H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff Journal: J Clin Invest Date: 1995-01 Impact factor: 14.808
Authors: S P Colgan; M B Resnick; C A Parkos; C Delp-Archer; D McGuirk; A E Bacarra; P F Weller; J L Madara Journal: J Immunol Date: 1994-09-01 Impact factor: 5.422
Authors: T Kohno; M T Brewer; S L Baker; P E Schwartz; M W King; K K Hale; C H Squires; R C Thompson; J L Vannice Journal: Proc Natl Acad Sci U S A Date: 1990-11 Impact factor: 11.205
Authors: R J Gregory; S H Cheng; D P Rich; J Marshall; S Paul; K Hehir; L Ostedgaard; K W Klinger; M J Welsh; A E Smith Journal: Nature Date: 1990-09-27 Impact factor: 49.962
Authors: L E M Willemsen; C C H M Schreurs; H Kroes; E J Spillenaar Bilgen; S J H Van Deventer; E A F Van Tol Journal: Dig Dis Sci Date: 2002-10 Impact factor: 3.199
Authors: Christina Foerg; Urs Ziegler; Jimena Fernandez-Carneado; Ernest Giralt; Hans P Merkle Journal: Pharm Res Date: 2007-03-03 Impact factor: 4.200
Authors: Stephan R Vavricka; Mark W Musch; Mikihiro Fujiya; Keri Kles; Laura Chang; Jyrki J Eloranta; Gerd A Kullak-Ublick; Ken Drabik; Didier Merlin; Eugene B Chang Journal: Pflugers Arch Date: 2005-11-19 Impact factor: 3.657
Authors: Andrew M Veitch; Lisa M Higgins; Mona Bajaj-Elliot; Michael J G Farthing; Thomas T MacDonald Journal: Int J Exp Pathol Date: 2003-06 Impact factor: 1.925
Authors: Nitsan Maharshak; Eun Young Huh; Chorlada Paiboonrungruang; Michael Shanahan; Lance Thurlow; Jeremy Herzog; Zorka Djukic; Roy Orlando; Rafal Pawlinski; Melissa Ellermann; Luke Borst; Siten Patel; Iris Dotan; Ryan B Sartor; Ian M Carroll Journal: Infect Immun Date: 2015-04-27 Impact factor: 3.441
Authors: Katherine M DiGuilio; Christina M Mercogliano; Jillian Born; Brendan Ferraro; Julie To; Brittany Mixson; Allison Smith; Mary Carmen Valenzano; James M Mullin Journal: World J Gastrointest Pathophysiol Date: 2016-05-15